Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Great time for Labs to use German news to their advantage

<< Previous

Bullboard Posts

Next >>

Comment by Olaf123on Feb 27, 2024 12:43pm

107 Views

Post# 35901722

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Great time for Labs to use German news to their advantage

I think Medif will at the very very best loose 2 millions in cash to cover their loses. I'm expecting -2.5m cash. We are going in the right direction. Imagine this narrative. A pharmaceutical company is profitable before their products launch. That's almost as rare as a unicorn.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023